Product Information
OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by BluePoint Laboratories, priced at $2.9968 per ML under NDC 68001053069. Its NADAC has been published 212 times since Aug 3, 2022.
FDA first approved this application on Apr 4, 2019.
Strength
2 mg/mL
Manufacturer
BluePoint LaboratoriesNDC
68001053069
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209995FDA Approved
4/4/2019
On Market Since
4/8/2022
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 212 times since Aug 3, 2022, and over the history we have for it it has declined 20.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9968 per ML |
|---|---|
| All-time high | $3.9682 (Feb 15, 2023) |
| All-time low | $2.8218 (Aug 17, 2022) |
| 52-week high | $3.6822 |
| 52-week low | $2.9954 |
| Median price | $3.3654 |
| Average price | $3.3744 |
| Largest weekly change | -25.4% (Aug 17, 2022) |
| Weeks tracked | 212 |
| Tracking since | Aug 3, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by BluePoint Laboratories, is $2.9968 per ML (NDC 68001053069), effective Aug 19, 2026.
How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 20.8%. It has been tracked across 212 weekly CMS publications since Aug 3, 2022.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?
Since Aug 3, 2022, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $2.8218 (Aug 17, 2022) to a high of $3.9682 (Feb 15, 2023), with a median of $3.3654 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLOPATADINE HCL 0.2% EYE DROP, is $2.0048 per ML — about 33% below OLOPATADINE HCL 0.2% EYE DROP.
Who manufactures OLOPATADINE HCL 0.2% EYE DROP?
OLOPATADINE HCL 0.2% EYE DROP (NDC 68001053069) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.